Logo image of CCJ

CAMECO CORP (CCJ) Stock Fundamental Analysis

NYSE:CCJ - New York Stock Exchange, Inc. - CA13321L1085 - Common Stock - Currency: USD

74.98  +2.28 (+3.14%)

Fundamental Rating

5

Overall CCJ gets a fundamental rating of 5 out of 10. We evaluated CCJ against 210 industry peers in the Oil, Gas & Consumable Fuels industry. While CCJ has a great health rating, its profitability is only average at the moment. CCJ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CCJ was profitable.
CCJ had a positive operating cash flow in the past year.
In multiple years CCJ reported negative net income over the last 5 years.
Each year in the past 5 years CCJ had a positive operating cash flow.
CCJ Yearly Net Income VS EBIT VS OCF VS FCFCCJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

CCJ has a Return On Assets of 2.65%. This is comparable to the rest of the industry: CCJ outperforms 44.76% of its industry peers.
CCJ's Return On Equity of 3.83% is in line compared to the rest of the industry. CCJ outperforms 42.38% of its industry peers.
The Return On Invested Capital of CCJ (4.57%) is worse than 61.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CCJ is significantly below the industry average of 23.80%.
The 3 year average ROIC (2.19%) for CCJ is below the current ROIC(4.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.65%
ROE 3.83%
ROIC 4.57%
ROA(3y)2.13%
ROA(5y)0.87%
ROE(3y)3.38%
ROE(5y)1.39%
ROIC(3y)2.19%
ROIC(5y)N/A
CCJ Yearly ROA, ROE, ROICCCJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

CCJ has a Profit Margin (7.55%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CCJ has grown nicely.
With a Operating Margin value of 17.38%, CCJ perfoms like the industry average, outperforming 49.52% of the companies in the same industry.
In the last couple of years the Operating Margin of CCJ has grown nicely.
CCJ's Gross Margin of 26.31% is on the low side compared to the rest of the industry. CCJ is outperformed by 61.90% of its industry peers.
In the last couple of years the Gross Margin of CCJ has grown nicely.
Industry RankSector Rank
OM 17.38%
PM (TTM) 7.55%
GM 26.31%
OM growth 3YN/A
OM growth 5Y26.35%
PM growth 3YN/A
PM growth 5Y6.65%
GM growth 3Y475.23%
GM growth 5Y13.99%
CCJ Yearly Profit, Operating, Gross MarginsCCJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CCJ is destroying value.
The number of shares outstanding for CCJ has been increased compared to 1 year ago.
The number of shares outstanding for CCJ has been increased compared to 5 years ago.
Compared to 1 year ago, CCJ has an improved debt to assets ratio.
CCJ Yearly Shares OutstandingCCJ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCJ Yearly Total Debt VS Total AssetsCCJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 10.14 indicates that CCJ is not in any danger for bankruptcy at the moment.
CCJ's Altman-Z score of 10.14 is amongst the best of the industry. CCJ outperforms 94.29% of its industry peers.
CCJ has a debt to FCF ratio of 1.37. This is a very positive value and a sign of high solvency as it would only need 1.37 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.37, CCJ belongs to the top of the industry, outperforming 86.19% of the companies in the same industry.
CCJ has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
CCJ has a better Debt to Equity ratio (0.15) than 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.37
Altman-Z 10.14
ROIC/WACC0.57
WACC8.05%
CCJ Yearly LT Debt VS Equity VS FCFCCJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

CCJ has a Current Ratio of 2.71. This indicates that CCJ is financially healthy and has no problem in meeting its short term obligations.
CCJ's Current ratio of 2.71 is amongst the best of the industry. CCJ outperforms 83.33% of its industry peers.
A Quick Ratio of 1.26 indicates that CCJ should not have too much problems paying its short term obligations.
The Quick ratio of CCJ (1.26) is better than 66.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 1.26
CCJ Yearly Current Assets VS Current LiabilitesCCJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

6

3. Growth

3.1 Past

CCJ shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
Measured over the past years, CCJ shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.32% on average per year.
Looking at the last year, CCJ shows a very strong growth in Revenue. The Revenue has grown by 29.88%.
Measured over the past years, CCJ shows a quite strong growth in Revenue. The Revenue has been growing by 10.98% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5Y41.32%
EPS Q2Q%23.08%
Revenue 1Y (TTM)29.88%
Revenue growth 3Y28.58%
Revenue growth 5Y10.98%
Sales Q2Q%24.45%

3.2 Future

Based on estimates for the next years, CCJ will show a very strong growth in Earnings Per Share. The EPS will grow by 39.39% on average per year.
The Revenue is expected to grow by 8.00% on average over the next years.
EPS Next Y139.17%
EPS Next 2Y88.33%
EPS Next 3Y59.73%
EPS Next 5Y39.39%
Revenue Next Year12.57%
Revenue Next 2Y11.04%
Revenue Next 3Y9.22%
Revenue Next 5Y8%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCJ Yearly Revenue VS EstimatesCCJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
CCJ Yearly EPS VS EstimatesCCJ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 159.53 indicates a quite expensive valuation of CCJ.
Based on the Price/Earnings ratio, CCJ is valued a bit more expensive than the industry average as 68.10% of the companies are valued more cheaply.
CCJ is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 46.72, which means the current valuation is very expensive for CCJ.
67.62% of the companies in the same industry are cheaper than CCJ, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, CCJ is valued a bit more expensive.
Industry RankSector Rank
PE 159.53
Fwd PE 46.72
CCJ Price Earnings VS Forward Price EarningsCCJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCJ is valued a bit more expensive than 72.86% of the companies in the same industry.
CCJ's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 61.75
EV/EBITDA 50.56
CCJ Per share dataCCJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CCJ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CCJ's earnings are expected to grow with 59.73% in the coming years.
PEG (NY)1.15
PEG (5Y)3.86
EPS Next 2Y88.33%
EPS Next 3Y59.73%

5

5. Dividend

5.1 Amount

CCJ has a yearly dividend return of 0.16%, which is pretty low.
Compared to an average industry Dividend Yield of 6.41, CCJ is paying slightly less dividend.
With a Dividend Yield of 0.16, CCJ pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.16%

5.2 History

The dividend of CCJ is nicely growing with an annual growth rate of 14.96%!
CCJ has been paying a dividend for at least 10 years, so it has a reliable track record.
As CCJ did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)14.96%
Div Incr Years1
Div Non Decr Years6
CCJ Yearly Dividends per shareCCJ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

28.00% of the earnings are spent on dividend by CCJ. This is a low number and sustainable payout ratio.
CCJ's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28%
EPS Next 2Y88.33%
EPS Next 3Y59.73%
CCJ Yearly Income VS Free CF VS DividendCCJ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
CCJ Dividend Payout.CCJ Dividend Payout, showing the Payout Ratio.CCJ Dividend Payout.PayoutRetained Earnings

CAMECO CORP

NYSE:CCJ (7/14/2025, 3:37:10 PM)

74.98

+2.28 (+3.14%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners73.47%
Inst Owner Change0.01%
Ins Owners0.38%
Ins Owner ChangeN/A
Market Cap32.64B
Analysts82.35
Price Target95.15 (26.9%)
Short Float %4.22%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield 0.16%
Yearly Dividend0.12
Dividend Growth(5Y)14.96%
DP28%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.43%
Min EPS beat(2)-19.32%
Max EPS beat(2)10.45%
EPS beat(4)1
Avg EPS beat(4)-39.82%
Min EPS beat(4)-103.96%
Max EPS beat(4)10.45%
EPS beat(8)2
Avg EPS beat(8)-19.84%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.88%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)7.16%
Revenue beat(4)1
Avg Revenue beat(4)-5.7%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)7.16%
Revenue beat(8)3
Avg Revenue beat(8)-7.71%
Revenue beat(12)5
Avg Revenue beat(12)-2.89%
Revenue beat(16)6
Avg Revenue beat(16)-3.32%
PT rev (1m)13.85%
PT rev (3m)16.5%
EPS NQ rev (1m)13.38%
EPS NQ rev (3m)77.3%
EPS NY rev (1m)16.47%
EPS NY rev (3m)8.04%
Revenue NQ rev (1m)-1.36%
Revenue NQ rev (3m)-2.1%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 159.53
Fwd PE 46.72
P/S 13.59
P/FCF 61.75
P/OCF 46.96
P/B 6.89
P/tB 6.93
EV/EBITDA 50.56
EPS(TTM)0.47
EY0.63%
EPS(NY)1.6
Fwd EY2.14%
FCF(TTM)1.21
FCFY1.62%
OCF(TTM)1.6
OCFY2.13%
SpS5.52
BVpS10.88
TBVpS10.82
PEG (NY)1.15
PEG (5Y)3.86
Profitability
Industry RankSector Rank
ROA 2.65%
ROE 3.83%
ROCE 6.48%
ROIC 4.57%
ROICexc 4.76%
ROICexgc 4.78%
OM 17.38%
PM (TTM) 7.55%
GM 26.31%
FCFM 22%
ROA(3y)2.13%
ROA(5y)0.87%
ROE(3y)3.38%
ROE(5y)1.39%
ROIC(3y)2.19%
ROIC(5y)N/A
ROICexc(3y)2.37%
ROICexc(5y)N/A
ROICexgc(3y)2.38%
ROICexgc(5y)N/A
ROCE(3y)3.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y32.23%
ROICexc growth 3YN/A
ROICexc growth 5Y32.37%
OM growth 3YN/A
OM growth 5Y26.35%
PM growth 3YN/A
PM growth 5Y6.65%
GM growth 3Y475.23%
GM growth 5Y13.99%
F-Score8
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.37
Debt/EBITDA 1.14
Cap/Depr 76.5%
Cap/Sales 6.93%
Interest Coverage 6.21
Cash Conversion 109.44%
Profit Quality 291.24%
Current Ratio 2.71
Quick Ratio 1.26
Altman-Z 10.14
F-Score8
WACC8.05%
ROIC/WACC0.57
Cap/Depr(3y)75.33%
Cap/Depr(5y)63%
Cap/Sales(3y)6.79%
Cap/Sales(5y)6.27%
Profit Quality(3y)244.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5Y41.32%
EPS Q2Q%23.08%
EPS Next Y139.17%
EPS Next 2Y88.33%
EPS Next 3Y59.73%
EPS Next 5Y39.39%
Revenue 1Y (TTM)29.88%
Revenue growth 3Y28.58%
Revenue growth 5Y10.98%
Sales Q2Q%24.45%
Revenue Next Year12.57%
Revenue Next 2Y11.04%
Revenue Next 3Y9.22%
Revenue Next 5Y8%
EBIT growth 1Y80.21%
EBIT growth 3YN/A
EBIT growth 5Y40.22%
EBIT Next Year150.71%
EBIT Next 3Y53.03%
EBIT Next 5Y30.88%
FCF growth 1Y249.42%
FCF growth 3Y24.49%
FCF growth 5Y8.95%
OCF growth 1Y173.99%
OCF growth 3Y25.47%
OCF growth 5Y11.43%